COVID Vaccine Developer/Manufacturer Announcements [selected]

Milestones :: Perspectives :: Research


COVID Vaccine Developer/Manufacturer Announcements [selected]


Press Releases – No new digest announcements identified


Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company’s COVID-19 Vaccine Candidate
:: Up to 400 million doses of the Company’s single-shot vaccine candidate will be made available to African Union member states
:: Availability of the vaccine is subject to national regulatory approvals
:: Data have demonstrated vaccine candidate protects against COVID-19 related hospitalization and death in broad geographic regions, including those with variants of significant concern
Mar 29, 2021, 03:09 ET


Press Releases
April 1, 2021
Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine

March 31, 2021
Moderna to Host Second Annual Virtual Vaccines Day on April 14, 2021

March 29, 2021
Moderna Announces Shipment of 100 Millionth Dose of its COVID-19 Vaccine to the U.S. Government


GSK to support manufacture of Novavax’ COVID-19 vaccine
– GSK to support manufacture of up to 60 million doses of Novavax’ COVID-19 vaccine
– Manufacturing to take place at GSK UK facility at Barnard Castle
Mar 29, 2021, 16:02 ET


Recent Press Releases
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents


Serum Institute
NEWS & ANNOUNCEMENTS – No new digest announcements identified


Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine
April 01, 2021